Consonance Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,433,774
| Closed | -$51.5M | – | 34 |
|
|
2019
Q2 | $51.5M | Sell |
1,433,774
-325,550
| -19% | -$11.7M | 3.65% | 10 |
|
|
2019
Q1 | $65M | Buy |
1,759,324
+243,902
| +16% | +$9.01M | 4.1% | 11 |
|
|
2018
Q4 | $65.3M | Hold |
1,515,422
| – | – | 4.8% | 10 |
|
|
2018
Q3 | $71.6M | Buy |
1,515,422
+27,931
| +2% | +$1.32M | 3.85% | 14 |
|
|
2018
Q2 | $74M | Buy |
1,487,491
+341,294
| +30% | +$17M | 4.77% | 8 |
|
|
2018
Q1 | $57M | Buy |
1,146,197
+229,747
| +25% | +$11.4M | 5.2% | 8 |
|
|
2017
Q4 | $34.1M | Buy |
+916,450
| New | +$34.1M | 3.08% | 14 |
|